Hip Replacement for Women with Osteoporosis
Author Information
Author(s): D. Popescu, R. Ene, C. Cirstoiu
Primary Institution: Orthopedics–Traumatology Clinic, University Hospital, Bucharest
Hypothesis
Can antiosteoporotic therapy improve bone quality and strength in postmenopausal women with hip arthrosis to facilitate hip surgery?
Conclusion
Improving bone mass and quality with bisphosphonate therapy is crucial for allowing hip arthroplasty in postmenopausal women with osteoporosis and hip arthrosis.
Supporting Evidence
- 12 out of 16 patients with improved bone density underwent successful hip replacement surgery.
- No femoral neck fractures occurred during surgery or the 12-month follow-up.
- All patients continued bisphosphonate therapy post-surgery.
Takeaway
This study shows that giving medicine to help bones before hip surgery can make the surgery safer and help women recover better.
Methodology
20 postmenopausal women were treated with bisphosphonates and monitored for bone density before undergoing hip replacement surgery.
Limitations
Some patients did not improve enough to qualify for surgery, and the study only included women aged 53-60.
Participant Demographics
Postmenopausal women aged 53-60 with osteoporosis and hip arthrosis.
Want to read the original?
Access the complete publication on the publisher's website